STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
41 hedge funds and large institutions have $147M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+9
Holders Change %
+28.13%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
14
Increased
10
Reduced
11
Closed
5
Calls
$5.3M
Puts
$67K
Net Calls
+$5.24M
Net Calls Change
+$5.24M
Top Buyers
Top Sellers
| 1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$815K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
3
Walleye Capital
New York
|
$562K |
| 4 |
BFM
4
Boothbay Fund Management
New York
|
$72K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$0 |
